Fixed dose combination - PDFSEARCH.IO - Document Search Engine

Fixed dose combination
Results: 323

#	Item
211	-------------------------WARNINGS AND PRECAUTIONS---------------------- HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRUVADA safely and effectively. See full pr Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:10:17 Purines Bristol-Myers Squibb Pharmacology Organofluorides Fixed dose combination Tenofovir Emtricitabine Reverse-transcriptase inhibitor Efavirenz Gilead Sciences Chemistry Organic chemistry
212	CLINICAL REVIEW Application Type[removed]Submission Number 022 Submission Code SE5 Add to Reading List Source URL: www.fda.gov Language: English Lopinavir/ritonavir Lopinavir Darunavir Antiretroviral drug Fixed-dose combination Tipranavir Atazanavir Ritonavir Efavirenz Chemistry Organic chemistry Protease inhibitors
213	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Add to Reading List Source URL: www.fda.gov Language: English Fixed dose combination Lopinavir/ritonavir Lopinavir Organic chemistry Drug safety Adverse Event Reporting System Antiretroviral drug Pharmacovigilance Protease inhibitors Chemistry Pharmacology
214	CDC Fact Sheet: PrEP: A New Tool for HIV Prevention Add to Reading List Source URL: stacks.cdc.gov Language: English - Date: 2014-09-11 08:40:04 Health Human sexuality Sexually transmitted diseases and infections Microbicides Pre-exposure prophylaxis Fixed dose combination IPrEx HIV Antiretroviral drug Medicine Gilead Sciences HIV/AIDS
215	Microsoft Word - MS PDL Proposed Changes Provider Notice V4[removed] Add to Reading List Source URL: www.medicaid.ms.gov Language: English - Date: 2014-08-25 16:54:47 Gilead Sciences Pharmacology Fixed dose combination Cyclopropanes Purines Antiretroviral drug Nevirapine Abacavir Efavirenz Chemistry Organic chemistry Bristol-Myers Squibb
216	Kentucky AIDS Drug Assistance Program Formulary Add to Reading List Source URL: chfs.ky.gov Language: English - Date: 2014-09-09 08:48:52 Gilead Sciences Pharmacology Non-nucleoside reverse transcriptase inhibitors Organofluorides Bristol-Myers Squibb Reverse-transcriptase inhibitor Emtricitabine ATC code J05 Antiretroviral drug Chemistry Organic chemistry Fixed dose combination
217	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Antiviral Drugs Advisory Committee (AVDAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Cente Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Gilead Sciences Clinical pharmacology Fixed dose combination Pre-exposure prophylaxis Food and Drug Administration Tenofovir/emtricitabine HIV Medicine HIV/AIDS Health
218	FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Antiviral Drugs Advisory Committee (AVDAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Cente Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Gilead Sciences Clinical pharmacology Fixed dose combination Pre-exposure prophylaxis Food and Drug Administration Tenofovir/emtricitabine HIV Medicine HIV/AIDS Health
219	Microsoft Word - ADAP_Formulary_09_01_2013.docx Add to Reading List Source URL: www.idph.state.il.us Language: English - Date: 2013-10-03 15:55:51 Organic chemistry Fixed dose combination Bristol-Myers Squibb Organochlorides Fixed-dose combination Emtricitabine/tenofovir/efavirenz Antiretroviral drug Tenofovir/emtricitabine Medical prescription Pharmacology Chemistry Gilead Sciences
220	Positively Aware HIV Treatment and Health September / October 2009 HIV: THE BASICS Add to Reading List Source URL: positivelyaware.com Language: English - Date: 2013-07-10 18:38:04 Organic chemistry HIV/AIDS Organofluorides Bristol-Myers Squibb Fixed dose combination Emtricitabine Tenofovir Efavirenz Antiretroviral drug Chemistry Gilead Sciences Medicine

UPDATE